IGF::OT::IGF DCTD TUMOR TISSUE ACQUISITION
$2,582,405N01FY2016CANIH
Leidos Biomedical Research, Inc., Frederick MD
Investigators
Abstract
NCI is requesting support to acquire serial tumor and blood samples, including pre-treatment, on-treatment, and off-treatment, from selected NCI NCORP sites for the study of mechanisms of sensitivity and resistance to anti-cancer agents.
View original record on NIH RePORTER →